Related Experiment Videos
Commentary on the consensus recommendations for the post mortem diagnosis of Alzheimer's disease
C A McLean1, K Beyreuther, C L Masters
1Department of Pathology, University of Melbourne, Parkville, Victoria, Australia.
Abstract:
The consensus recommendations for the post mortem diagnosis Alzheimer's disease (AD) highlight the difficulties in establishing a pathological diagnosis in brains from clinically demented individuals with both certainty and uniformity. There is, however, a need for diagnostic guidelines that are relatively simple, inexpensive, and adaptable to general pathologists and different laboratories. The current Consortium to Establish a Registry for Alzheimer's disease (CERAD) criteria and the recommendations in the consensus document giving three probabilistic categories for diagnosis go a long way towards establishing a uniform approach for the diagnosis of AD. However, more uniformity could be adopted in the topography of sectioning to enhance diagnostic and future research comparisons. We also recommend that immunohistochemistry for beta A4 (A beta) amyloid and tau-reactive neurofibrillary changes, in addition to hematoxylin and eosin stains, should become the basis for histological diagnosis. We agree with the guidelines concerning documentation of all AD changes. Until a clearer understanding of the early changes of AD is established, strict observation and recording are the pathologists' best diagnostic skills. The ill-defined diagnostic areas of AD continue to prompt the need for a new method of detection of the underlying pathologic process.
Insights
Establishing a definitive post mortem diagnosis of Alzheimer's disease (AD) is challenging. This study proposes simpler, cost-effective guidelines for pathologists to improve diagnostic uniformity and accuracy in Alzheimer's disease detection.
Area of Science:
- Neuropathology
- Neurodegenerative Diseases
- Biomarkers
Background:
- Post mortem diagnosis of Alzheimer's disease (AD) faces challenges in certainty and uniformity.
- Existing diagnostic criteria, like CERAD, offer probabilistic categories but require refinement.
- There is a need for accessible, inexpensive diagnostic guidelines for general pathologists.
Purpose of the Study:
- To propose enhanced diagnostic guidelines for post mortem Alzheimer's disease (AD) diagnosis.
- To improve uniformity and cost-effectiveness in pathological diagnosis.
- To recommend standardized histological techniques for AD detection.
Main Methods:
- Review of current consensus recommendations for AD diagnosis.
- Analysis of existing criteria (e.g., CERAD) for pathological diagnosis.
- Proposal for standardized brain sectioning topography and immunohistochemistry.
Main Results:
- Current criteria provide a foundation for uniform AD diagnosis.
- Standardized topography in sectioning can enhance diagnostic comparisons.
- Immunohistochemistry for beta A4 amyloid and tau is recommended alongside H&E stains.
Conclusions:
- Simpler, adaptable guidelines are needed for reliable post mortem AD diagnosis.
- Standardization of histological methods and topography is crucial for uniformity.
- Continued research is necessary to understand early AD changes and improve detection methods.